Gene Therapy for Cardiovascular Disease: Clinical Perspectives

Area of Science:

• Cardiovascular Medicine
• Molecular Biology
• Biotechnology

Background:

• Cardiovascular disease (CVD) is a leading cause of death, with current treatments having limitations.
• Cardiac gene therapy offers a potential alternative for CVD management.
• Preclinical studies show promise, but clinical translation remains challenging.

Purpose of the Study:

• To review recent preclinical and clinical studies on cardiac gene therapy for CVD.
• To discuss the limitations and challenges hindering clinical application.

Main Methods:

• Comprehensive literature review of preclinical and clinical studies.
• Analysis of gene transduction efficiency, immune reactions, and off-target effects.
• Evaluation of successful and unsuccessful clinical trial outcomes.

Main Results:

• Significant success in animal models for various CVDs.
• Limited success in clinical applications, with few positive early trials.
• Persistent obstacles include low gene transduction efficiency and adverse immune responses.

Conclusions:

• Cardiac gene therapy holds potential but requires further research to overcome existing limitations.
• Addressing challenges in vector efficiency and immunogenicity is crucial for clinical success.
• Continued investigation into safe and effective gene delivery is essential for advancing CVD treatment.